Media coverage
2
Media coverage
Title Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor Media name/outlet Tullahoma News Country/Territory United States Date 24/04/19 URL https://www.tullahomanews.com/news/business/forbius-first-patient-dosed-in-a-phase-b-myelofibrosis-trial/article_c166cb16-3c57-5178-a3c8-515d1b4be35c.html Persons Ronald Hoffman Title Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor Media name/outlet Manchester Times Country/Territory United States Date 24/04/19 URL https://www.manchestertimes.com/news/business/forbius-first-patient-dosed-in-a-phase-b-myelofibrosis-trial/article_5ccf867e-b2b0-50c6-a8b3-d9d3eb908f5a.html Persons Ronald Hoffman